Learning the lessons of failed trials in mild, moderate and severe Alzheimer’s disease, Novartis is planning to study two new treatments on patients who are yet to show any symptoms, hoping to succeed where many others have slipped and delay the onset of the memory-destroying ailment.

…read more

Source: Novartis plans to test Alzheimer’s drugs in patients without symptoms


0 No comments